{"organizations": [], "uuid": "6f14e1384f406e1c166862486c9b6a20da372c7a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180213.html", "section_title": "Archive News &amp; Video for Tuesday, 13 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bioverativ-q4-revenue-rose-283-per/brief-bioverativ-q4-revenue-rose-28-3-percent-to-328-7-million-idUSASB0C5IE", "country": "US", "domain_rank": 408, "title": "Bioverativ Q4 Revenue Rose 28.3 Percent To $328.7 Million", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.12, "site_type": "news", "published": "2018-02-14T05:24:00.000+02:00", "replies_count": 0, "uuid": "6f14e1384f406e1c166862486c9b6a20da372c7a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bioverativ-q4-revenue-rose-283-per/brief-bioverativ-q4-revenue-rose-28-3-percent-to-328-7-million-idUSASB0C5IE", "ord_in_thread": 0, "title": "Bioverativ Q4 Revenue Rose 28.3 Percent To $328.7 Million", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "bioverativ inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 13 (Reuters) - Bioverativ Inc:\n* BIOVERATIV REPORTS FOURTH QUARTER AND FULL YEAR 2017 PERFORMANCE\n* Q4 REVENUE ROSE 28.3 PERCENT TO $328.7 MILLION * QTRLY ‍SHR $1.30​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T05:24:00.000+02:00", "crawled": "2018-02-14T12:52:33.020+02:00", "highlightTitle": ""}